Librería: Bay State Book Company, North Smithfield, RI, Estados Unidos de America
EUR 135,76
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: very_good.
EUR 436,55
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Stanley T. CrookeExtensively revised and updated, Antisense Drug Technology: Principles, Strategies, and Applications, Second Edition reflects the logarithmic progress made in the past four years of oligonucleotide-based therapies, and, in.
Librería: Chiron Media, Wallingford, Reino Unido
EUR 576,11
Cantidad disponible: 5 disponibles
Añadir al carritoHardcover. Condición: New.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 579,10
Cantidad disponible: 10 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 603,95
Cantidad disponible: 10 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 609,70
Cantidad disponible: 10 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 631,34
Cantidad disponible: 10 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por Taylor & Francis Inc Jul 2007, 2007
ISBN 10: 0849387965 ISBN 13: 9780849387968
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 540,00
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. Neuware - Divided into five parts, this book offers an introduction to the mechanism of antisense drug action including the RNase H mechanism, small RNA silencing pathways, and the potential therapeutics of splice switching oligonucleotides.
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 1.254,02
Cantidad disponible: 10 disponibles
Añadir al carritoCondición: New. Divided into five parts, this book offers an introduction to the mechanism of antisense drug action including the RNase H mechanism, small RNA silencing pathways, and the potential therapeutics of splice switching oligonucleotides. Editor(s): Crooke, Stanley T. Num Pages: 848 pages, 243 black & white illustrations, 13 colour illustrations, 73 black & white tables, 18 bla. BIC Classification: TDCW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 188 x 265 x 56. Weight in Grams: 1766. . 2007. 2nd Edition. hardcover. . . . .
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
EUR 1.097,44
Cantidad disponible: 10 disponibles
Añadir al carritoCondición: New. Divided into five parts, this book offers an introduction to the mechanism of antisense drug action including the RNase H mechanism, small RNA silencing pathways, and the potential therapeutics of splice switching oligonucleotides. Editor(s): Crooke, Stanley T. Num Pages: 848 pages, 243 black & white illustrations, 13 colour illustrations, 73 black & white tables, 18 bla. BIC Classification: TDCW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 188 x 265 x 56. Weight in Grams: 1766. . 2007. 2nd Edition. hardcover. . . . . Books ship from the US and Ireland.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 1.066,32
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Brand New. 2nd edition. 825 pages. 10.00x7.25x2.00 inches. In Stock.
Idioma: Inglés
Publicado por Taylor & Francis Inc, Bosa Roca, 2007
ISBN 10: 0849387965 ISBN 13: 9780849387968
Librería: AussieBookSeller, Truganina, VIC, Australia
EUR 1.293,43
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. Extensively revised and updated, Antisense Drug Technology: Principles, Strategies, and Applications, Second Edition reflects the logarithmic progress made in the past four years of oligonucleotide-based therapies, and, in particular, antisense therapeutics and research. Interpreting lessons learned from the clinical trials of first generation drugs, the book evaluates the technology as a whole and offers new directions and avenues of research and development. Divided into five parts, the book begins with a thorough introduction to the mechanism of antisense drug action including the RNase H mechanism, small RNA silencing pathways, and the potential therapeutics of splice switching oligonucleotides. Leading researchers demonstrate the basics of oligonucleotide therapeutics in part two by delineating medicinal chemistry, pharmacokinetics, and delivery routes such as liposomal formulations for nucleic acid delivery. Part three details hybridization based drugs and considers the dramatic advances represented by 2' methoxyethyl chimeric antisense inhibitors and duplex RNA drugs.Other chemical classes of drugs and mechanisms of action are described in part four with further discussions on improving the second generation antisense drugs. The final part delves deeply into therapeutic applications. Contributing authors examine the potential of antisense drugs for the alleviation of cardiovascular diseases, metabolic diseases, inflammatory diseases, cancer, neurological disorders, and immune modulation. Presenting a highly detailed, lucid discussion of the remarkable advances in the field, Antisense Drug Technology: Principles, Strategies, and Applications, Second Edition provides the platform for researchers to continue to aggressively pursue the great opportunity represented by this exciting technology. Divided into five parts, this book offers an introduction to the mechanism of antisense drug action including the RNase H mechanism, small RNA silencing pathways, and the potential therapeutics of splice switching oligonucleotides. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Idioma: Inglés
Publicado por Taylor & Francis Inc, Bosa Roca, 2007
ISBN 10: 0849387965 ISBN 13: 9780849387968
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
EUR 850,80
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. Extensively revised and updated, Antisense Drug Technology: Principles, Strategies, and Applications, Second Edition reflects the logarithmic progress made in the past four years of oligonucleotide-based therapies, and, in particular, antisense therapeutics and research. Interpreting lessons learned from the clinical trials of first generation drugs, the book evaluates the technology as a whole and offers new directions and avenues of research and development. Divided into five parts, the book begins with a thorough introduction to the mechanism of antisense drug action including the RNase H mechanism, small RNA silencing pathways, and the potential therapeutics of splice switching oligonucleotides. Leading researchers demonstrate the basics of oligonucleotide therapeutics in part two by delineating medicinal chemistry, pharmacokinetics, and delivery routes such as liposomal formulations for nucleic acid delivery. Part three details hybridization based drugs and considers the dramatic advances represented by 2' methoxyethyl chimeric antisense inhibitors and duplex RNA drugs.Other chemical classes of drugs and mechanisms of action are described in part four with further discussions on improving the second generation antisense drugs. The final part delves deeply into therapeutic applications. Contributing authors examine the potential of antisense drugs for the alleviation of cardiovascular diseases, metabolic diseases, inflammatory diseases, cancer, neurological disorders, and immune modulation. Presenting a highly detailed, lucid discussion of the remarkable advances in the field, Antisense Drug Technology: Principles, Strategies, and Applications, Second Edition provides the platform for researchers to continue to aggressively pursue the great opportunity represented by this exciting technology. Divided into five parts, this book offers an introduction to the mechanism of antisense drug action including the RNase H mechanism, small RNA silencing pathways, and the potential therapeutics of splice switching oligonucleotides. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Idioma: Inglés
Publicado por Taylor & Francis Group, 2007
ISBN 10: 0849387965 ISBN 13: 9780849387968
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 703,53
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. xvii 825 12 of lates 2nd Edition.
Idioma: Inglés
Publicado por Taylor & Francis Group, 2007
ISBN 10: 0849387965 ISBN 13: 9780849387968
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 748,12
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. xvii 825 12 of lates.
Idioma: Inglés
Publicado por Taylor & Francis Group, 2007
ISBN 10: 0849387965 ISBN 13: 9780849387968
Librería: Majestic Books, Hounslow, Reino Unido
EUR 677,11
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. xvii 825 12 of lates Illus. This item is printed on demand.